CXMT's blockbuster debut adds a new competitive threat to Micron's conventional DRAM business

What happened

Chinese memory maker CXMT raised billions in its Shanghai IPO, giving it ample capital to accelerate expansion in conventional DRAM production. Micron's stock fell 6.9% before CXMT began trading, reflecting investor concern that increased Chinese supply could pressure DRAM pricing. The DeepValue report already identified that if HBM demand weakens, suppliers could shift capacity to conventional DRAM, and CXMT's funding magnifies that risk. While Micron's near-term AI-driven HBM demand and strategic customer agreements provide a buffer, the structural competitive landscape in conventional DRAM is deteriorating. Longer-term, CXMT's ramping capacity could compress margins when Micron's new fabs come online in 2027.

Implication

Investors should monitor CXMT's capacity build-out and any signs of conventional DRAM oversupply; if CXMT ramps quickly, it could compress Micron's margins in 2027+ when new capacity comes online, making the HBM-to-conventional reallocation risk more acute.

Thesis delta

The prior thesis assumed limited competitive threat from Chinese memory makers due to technology gaps and restrictions. CXMT's IPO changes that—it now has substantial funding to invest in conventional DRAM, increasing the likelihood of oversupply in that segment independently of HBM dynamics. This shifts the risk profile from purely cyclical to also structural in conventional DRAM, reinforcing the need to watch for reallocation from HBM to conventional DRAM.